Sg Americas Securities, LLC / ABT
Sg Americas Securities, LLC’s Abbott Laboratories Position
Does Sg Americas Securities, LLC own Abbott Laboratories (ABT)? Yes — 2.06M shares worth $212M (+0.23% of its 13F portfolio) as of Q1 2026, up from 962.8K shares the prior filed quarter.
Position Value
$212M
Q1 2026
Shares
2.06M
% of Portfolio
+0.23%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.06M | $212M | +0.23% |
| Q4 2025 | 962.8K | $121M | +0.15% |
| Q3 2025 | 590.3K | $79M | +0.27% |
| Q2 2025 | 199.9K | $27M | +0.11% |
| Q1 2025 | 120.2K | $16M | +0.05% |
| Q4 2024 | 33.7K | $4M | +0.02% |
| Q3 2024 | 338.0K | $39M | +0.14% |
| Q2 2024 | 447.0K | $46M | +0.27% |
| Q1 2024 | 508.6K | $58M | +0.28% |
| Q4 2023 | 225.0K | $25M | +0.23% |
| Q3 2023 | 48.2K | $5M | +0.05% |
| Q2 2023 | 357.1K | $39M | +0.29% |
| Q1 2023 | 142.9K | $14M | +0.17% |
| Q4 2022 | 6.8K | $750,000 | +0.01% |
| Q3 2022 | 195.1K | $19M | +0.23% |
| Q2 2022 | 109.6K | $12M | +0.13% |
| Q1 2022 | 154.9K | $18M | +0.13% |
| Q4 2021 | 45.6K | $6M | +0.03% |
| Q3 2021 | 166.3K | $20M | +0.09% |
| Q2 2021 | 279.6K | $32M | +0.15% |
| Q1 2021 | 274.8K | $33M | +0.17% |
| Q4 2020 | 235.6K | $26M | +0.14% |
| Q3 2020 | 93.8K | $10M | +0.06% |
| Q2 2020 | 108.7K | $10M | +0.08% |
| Q1 2020 | 180.3K | $14M | +0.13% |
| Q4 2019 | 23.0K | $2M | +0.02% |
| Q3 2019 | 27.0K | $2M | +0.02% |
| Q2 2019 | 198.7K | $17M | +0.12% |
| Q1 2019 | 107.3K | $9M | +0.08% |
| Q4 2018 | 456.3K | $33M | +0.29% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Sg Americas Securities, LLC’s full portfolio or all institutional holders of ABT.